Results 171 to 180 of about 182,063 (264)
This review systematically summarizes the major molecular mechanisms governing TAM polarization and their coordinated interactions. It further highlights recent advances in nanoagonist‐based strategies that intervene in these pathways to reprogram TAMs, critically discussing their therapeutic potential, current limitations, and translational prospects.
Siqi Fang +7 more
wiley +1 more source
Advances in pharmacotherapy for fibrotic interstitial lung disease. [PDF]
Feng X, Deng M, Miao J, Zheng Z, Hou G.
europepmc +1 more source
Balancing Act: Se─M bond serving as the fulcrum of the balance scale to compare the different weight of toxicity and therapeutic effects in biological environment. ABSTRACT The synthesis and characterization of organo‐selenium compounds have attracted considerable interest for decades, driven by the search for efficient catalysts and bioinspired ...
Matteo Filippi +6 more
wiley +1 more source
Prevalence and screening of interstitial lung disease in rheumatoid arthritis. [PDF]
Gono T.
europepmc +1 more source
Intelligent Automation Improved Efficiency in Pharmacovigilance Safety Signal Assessment
Pharmacovigilance is the science involving the detection, assessment, understanding, and prevention of adverse events associated with drugs, biologics, or medical devices. In pharmacovigilance, information that suggests a new potential causal relationship between an intervention and an adverse event is called a safety signal. Following their detection,
Jeffrey Warner +3 more
wiley +1 more source
Diaphragmatic Ultrasound in Fibrosing Interstitial Lung Disease: A Systematic Review of Current Evidence. [PDF]
Patabendige S +7 more
europepmc +1 more source
Ulcerated Gottron's papules in anti‐MDA5 dermatomyositis
Arthritis &Rheumatology, Accepted Article.
Philipp Jud, Monica D'Orazio
wiley +1 more source
Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset
Considering the high unmet medical need in people with non‐small cell lung cancer (NSCLC), the drug assessment for targeted therapies often rely on small populations and single‐arm trials, challenging the evaluation by regulatory authorities, health technology assessment bodies (HTAb), and clinicians.
Geeske F. Grit +6 more
wiley +1 more source
Analysis of Factors Associated With Interstitial Lung Disease in Treatment-Naïve Rheumatoid Arthritis Patients and Development of a Classification Nomogram. [PDF]
Lu L +6 more
europepmc +1 more source

